Position in QGEN
as of Mar 31, 2026
· filed May 8, 2026
Position Value
$224,824
-$1,498,662 QoQ
Shares Held
5,615
-85.4% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2025
3 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in QGEN Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Mar 31, 2026Andra AP-fonden holds $138,831,302 across 11 Diagnostics & Research names. QGEN ranks #10 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
57,814 | $28,417,315 | |
| 2 | IQV |
Iqvia Holdings Inc.
|
121,405 | $20,704,408 | |
| 3 | IDXX |
Idexx Laboratories Inc /De
|
29,531 | $16,593,173 | |
| 4 | NTRA |
Natera, Inc.
|
82,737 | $16,546,572 | |
| 5 | LH |
Labcorp Holdings Inc.
|
54,662 | $14,584,368 | |
| 6 | DHR |
Danaher Corp /De/
|
76,642 | $14,531,323 | |
| 7 | A |
Agilent Technologies, Inc.
|
101,500 | $11,568,970 | |
| 8 | ILMN |
Illumina, Inc.
|
84,137 | $10,370,726 |
All Filings in QGEN
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $224,824 | 5,615 | Shares | Sole | 2026-05-08 | |
| 2025-09-30 | $1,723,486 | 38,574 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $1,427,622 | 29,705 | Shares | Sole | 2025-08-06 | |
| No filing history on record for this holder in this stock. | ||||||